Lipocine Inc.
LPCN- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001535955
In the last 90 days, Lipocine Inc. insiders filed 2 open-market purchases and 0 sales; 36 institutions reported holding it in 13F filings for Q2 2026, worth $7.63M in total; no superinvestor holds it.
Q2 2025 vs. Q1 2025
How the institutions holding Lipocine Inc. changed between Q1 2025 and Q2 2025.
All holders in Q2 2025All holders in Q1 2025
| Measure | Q1 2025 | Q2 2025 | Change |
|---|---|---|---|
| Holders | 19 | 18 | −1 |
| Shares | 517.5K | 528.5K | +11.0K (+2.1%) |
| Value | $1.65M | $1.67M | +$24.4K (+1.5%) |
New holders (1)
Institutions that held Lipocine Inc. at the end of Q2 2025 but not at the end of Q1 2025.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Barclays PLC | 9,412 | $29.7K | 0.00% |
Sold out (2)
Institutions that held Lipocine Inc. at the end of Q1 2025 and filed for Q2 2025 without it.
| Institution | Shares, Q1 2025 | Value, Q1 2025 |
|---|---|---|
| FMR LLC | 237 | $754 |
| JPMorgan Chase & Co | 11 | $35 |